Skip to content
healthcare.dev

Nevirapine

NDC 0378-4890, nevirapine, tablet, extended release, from Mylan Pharmaceuticals Inc..

Product NDC
0378-4890
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205651
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0378-4890 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEVIRAPINE400 mg/1

Pharmacologic classes

Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
0378-4890-930037848909330 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-4890-93)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/690da74b-2481-47fc-93ae-8340e0caf0a4
  • NADAC price for package 00378489093

    GET /v1/drugs/nadac/00378489093

Use it

Look up 0378-4890 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0378-4890 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0378-4890. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.